Category: Clinical Research/Diagn.
FDA Approves NGS-Based Companion Diagnostic for EGFR Exon20 Insertion Mutant Non-Small Cell Lung Cancer Tumor Tissue
FDA Approves NGS-Based Companion Diagnostic for EGFR Exon20 Insertion Mutant Non-Small Cell Lung Cancer Tumor Tissue CARLSBAD, Calif., Dec. 9, 2021 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) has granted premarket approval to Thermo Fisher Scientific’s Oncomine Dx Target Test as a companion diagnostic (CDx) to help identify non-small cell lung cancer (NSCLC) patients... Read more
GE Healthcare Introduces An Industry-First Modular, Scalable CT Platform to Minimize Technology Obsolescence & Maximize Clinical Capabilities
GE Healthcare introduces the industry’s first[i] computed tomography (CT) platform with built-in scalability and upgradability[ii] The new Revolution Apex platform offers the world’s fastest gantry speed: 0.23 seconds per rotation and 19.5 millisecond effective temporal resolution to freeze cardiac motion[iii] Altogether, the company’s CT platform enables healthcare facilities to keep up with the latest technology... Read more
GE Healthcare Introduces An Industry-First Modular, Scalable CT Platform to Minimize Technology Obsolescence & Maximize Clinical Capabilities
https://www.ge.com/news/ Read more
GE Healthcare Introduces An Industry-First Modular, Scalable CT Platform to Minimize Technology Obsolescence & Maximize Clinical Capabilities
GE Healthcare introduces the industry’s first[i] computed tomography (CT) platform with built-in scalability and upgradability[ii] The new Revolution Apex platform offers the world’s fastest gantry speed: 0.23 seconds per rotation and 19.5 millisecond effective temporal resolution to freeze cardiac motion[iii] Altogether, the company’s CT platform enables healthcare facilities to keep up with the latest technology... Read more
Cancer Patients may get Faster and more Personalized Treatment as result of Collaboration between GE Healthcare, University of Cambridge and Addenbrooke’s hospital
Teams plan to cooperate on the development of a machine learning-based solution, aiming to improve care for cancer patients by giving cancer care teams access to complex data and information The potentially transformative solution will initially focus on ovarian cancer and will then expand for use in breast and kidney cancer. Cambridge/Chalfont St Giles, UK;... Read more
Roche launches cobas 5800, a new molecular diagnostics system to expand access to testing and improve patient care
Infectious diseases, such as those infections transmitted via respiratory, sexually and transplant, are becoming increasingly difficult to manage and represent an ever-growing medical need for millions of patients worldwide. Access to accurate and reliable diagnostic tests help clinicians improve patient care, limit healthcare spending and contribute to protecting public health. The cobas 5800 System is... Read more
Karolinska Institutet & MedTechLabs Kickoff The World’s First Clinical Evaluation of GE Healthcare’s Photon Counting CT Technology with Deep Silicon Detectors
Photon counting CT has the promise to further expand the capabilities of traditional CT Karolinska Institutet and MedTechLabs’ pilot study represents the first of its kind to test pure silicon CT detector technology for photon counting CT in a clinical setting The project is the result of close collaborations between healthcare, academia and business Chicago,... Read more
Karolinska Institutet & MedTechLabs Kickoff The World’s First Clinical Evaluation of GE Healthcare’s Photon Counting CT Technology with Deep Silicon Detectors
Photon counting CT has the promise to further expand the capabilities of traditional CT Karolinska Institutet and MedTechLabs’ pilot study represents the first of its kind to test pure silicon CT detector technology for photon counting CT in a clinical setting The project is the result of close collaborations between healthcare, academia and business Chicago,... Read more
Ronapreve approved by European Commission to treat non-hospitalised COVID-19 patients and for prophylaxis of the disease
EU marketing authorisation follows approvals in Japan, the United Kingdom and Australia Approval based on data demonstrating Ronapreve reduced risk of hospitalisation in certain patients with mild to moderate disease and reduced risk of symptomatic COVID-19 infections in people exposed to the virus Basel, 12 November 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today... Read more